Humana's stock has shown resilience, boosted by a 5% increase in Medicare Advantage payments. Read my analysis of HUM stock.

Humana (NYSE:HUM) recently announced a significant Fixed-Income Offering valued at approximately $250 million, alongside a partnership between CenterWell and Icon Health to enhance senior care. These ...

Humana shares jumped 11% in extended trading on Monday after the federal government said it would pay Medicare insurers more next year than previously expected. Monitor these key chart levels.

The stock rose 11% to $283.50 in after-hours trading Monday. Below, we take a closer look at Humana’s chart and apply technical analysis to identify key price levels worth watching out for.

But Humana Inc.'s stock (HUM) rose more than 11% in Monday's after-hours action, while CVS Health Corp.'s stock (CVS) gained 6.5% and UnitedHealth Group Inc.'s stock (UNH) advanced nearly 6%.

But Humana Inc.'s stock (HUM) rose more than 11% in ... they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that ...

CVS stock fell from $80 per share to <$45 per share, and Humana stock from >$500 per share ... lies with drug pricing. Analysis - Despite Positive Guidance, UnitedHealth Stock Remains At Risk ...

In contrast, the analysts noted that Humana, along with Elevance Health (previously known as Anthem), displayed the weakest reserve positioning. The analysis takes into account each company’s ...

In contrast, the analysts noted that Humana, along with Elevance Health (previously known as Anthem (NYSE:ELV)), displayed the weakest reserve positioning. The analysis takes into account each company ...

The stock is up 6.9% since reporting and currently trades at $285.15. Is now the time to buy Humana? Access our full analysis ...